Blue Horseshoe Stocks: QSIM, USRM Updates & More

U.S. Stem Cell, Inc. USRM

We tagged USRM in our report on Monday for the first time in quite awhile, and reported back to our readers yesterday morning on the excellent 72% push it made from .014-.0241. We also mentioned the strength of its close and increased volume, noting that we’d want to continue keeping a close eye on the stock.

Yesterday’s session provided a prime example of why we doubled down on USRM for the second day in a row, with the stock streaking to an impressive new high. It traded up from it low of .0245 and smashed through the nickel barrier, reaching .0545 for a hefty intraday gain of 122%

From our observed low on Monday, the move represented an overall two-day upswing of 289%


QuantumSphere, Inc. QSIM

We noticed some heightened activity in QSIM in yesterday morning’s premarket scan, and included the stock in our extended watchlist for the day. It was a good thing that we did, because the stock put up an awesome performance, continuously ramping its way up the chart for essentially the entire session.

From its early low of .0043, QSIM was shot out of a cannon and reached a high of .011 just prior to the closing bell, for an intraday increase of 156% which came on heavy volume, on the order of seven times the 30-day average.

With such a bullish session, we’re certainly going to want to keep QSIM on tap for further potential moves, be it an immediate continuation of this bullish trend, or a dip-and-rip scenario.


Vapor Group, Inc. VPOR

Rounding off yesterday’s top movers was VPOR. Like the previously-mentioned play, we caught this one on our routine morning scan and took note of an increase in volume and price action in the prior session.

The momentum carried over nicely, with VPOR trading up from a low of .00355 and reaching .0053, for an intraday pop of 49% It marked the third straight day of higher highs and higher lows for the stock, so it too will remain on our watchlist moving forward.


Lowes Companies, Inc. LOW – Options Idea

Lowes joined the earnings bonanza this morning with an impressive set of figures in their Q4 report. We are going to be tracking a range of short-term options to possibly take advantage of the commotion.

Our targets are going to be the LOW Weekly $79-81 Calls.


Extended Watchlist:
CCTL, RSII, MYHI, HMCP, OTTV, THCT

Blue Horseshoe Stocks: Potential Bottom-Play, HMCP Update & More

GAIN Capital Holdings, Inc. GCAP

GCAP began to get hammered on the heels of yesterday’s announcement by the Swiss National Bank that it would move interest rates caused some volatility in the Swiss franc.

The stock is still getting crushed in the premarket today despite the fact that the move by the Swiss does not materially affect the company, as stated in a commentary released by BCAP yesterday afternoon. >>> READ PR

Currently it has been beaten down to the 6.50-area; its lowest levels since October, so what we’re going to want to do is monitor this play for an eventual bottom-bounce. This is exactly the type of knee-jerk pullback we like to catch, as the recovery can often be extremely profitable for quick-witted traders.


Heritage Media Corp. HMCP

We first brought HMCP to our readers’ attention on New Year’s Eve, and discussed it most recently last Thursday. With such a low float, HMCP is susceptible to rapid movement on relatively little buying/selling pressure, and in the intervening time between those two reports, we witnessed a series of heavy swings in the stock cumulatively totaling 200%

We pointed out that the patterns were making a bullish flag formation on the chart, and it did turn out to be a prelude to further gains. On Monday we observed a low of .003, and yesterday the stock registered a new high for us at .0077, which adds another 156% swing to the already impressive moves we had witnessed previously.

Indicators are still looking ripe as illustrated on the following snapshot, so HMCP will be something that we keep a close eye on into next week.


Extended Watchlist:
RVP, SDRL, EOPN, IAG, PBR, BBEP

Blue Horseshoe Stocks: ARNA Recap & More

Arena Pharmaceuticals, Inc. ARNA

You have to go a long way back to find our very first coverage of ARNA. It was May 11th, 2012 that we first mentioned this stock as an item to have on long-term watch. At that time the company had an obesity treatment that was awaiting FDA approval.

The public sentiment during that summer was that FDA approval was all but in the bag, and as we waited the stock began a monstrous run from a low of 5.44 to the day of its approval when it hit 13.50, an overall increase of 148% It would be a very long time before we talked about ARNA again.

The next time was fairly recently on November 3rd when we included ARNA on our Extended Watchlist, and over a period of a few sessions, saw the stock make a decent move from a low of 4.12 to 4.76. After that, it endured a series of incremental pullbacks over the next several weeks.

Yesterday morning, in a stroke of superb timing we tagged the stock in our watchlist once again, and what it did next blew the run we witnessed in November right out of the water!  Coinciding with the announcement of positive top-line results on another of the company’s treatments (this one for autoimmune disease) ARNA made a huge intraday run from a low of 3.66 to all the way up to 6.09. That’s a hefty 66% increase in a single session, and it came on approximately 20X the 3-month average volume, so cheers are in order for anyone who took advantage of our timely alert!


Heritage Media Corp. HMCP

Since we mentioned HMCP for the first time on New Year’s Eve, the stock has provided us with a few quality swing-trade opportunities. That day the stock traded in a range from .0047 to .0068, an intraday gain of 45% In following sessions we then observed subsequent swings from .0037-.0064 (+73%) and .0034-.0062 (+82%) making HMCP a flipper’s dream.

As we point out on the snapshot below, what has formed on the chart is known as a bullish flag, which is known to be a signal of further gains. Couple that with an RSI that’s screaming toward the power zone, and it makes HMCP one that we’ll really need to watch closely as we head into week’s end.


Extended Watchlist:
BIND, BIOD, FOLD, NRX, CYRN, AVEO, ACUR, PLX, S

Blue Horseshoe Stocks: Final Report of 2014

Good Morning Traders! Here it is- the final report of 2014! We had an amazing year, with huge gainers popping out of the woodwork left, right, and center! We want to take this opportunity to thank all of our readers for being a part of our community, wish you all a Happy New Year while reminding everyone that the best is yet to come… Each year our resolution remains the same: To make the upcoming year our best one ever! We’ve succeeded time and time again, and have no reason to believe that 2015 will be any different so be sure to stay with us! Cheers!


NeuroDerm Ltd. NDRM
NDRM exceeded all expectations yesterday after we caught it on an early morning news scan; it spent the entire day in full-on breakout mode setting records in both price and volume, trading almost 27X the norm over the six week period since the stock’s IPO.

Positive response to yesterday’s early morning press statement hurtled NDRM from an early low of 8.16 all the way up to 19.07 just prior to the close, making gains of up to 134% possible.

We’ll still be standing at the ready for an eventual course correction and chance for a dip-and-rip maneuver, but any way you slice it, NDRM is getting marked down as a huge winner. It’s a great way to close out what has, on the whole, been an absolutely stellar year.

NeuroDerm Announces Topline Results of Phase IIa Pharmacokinetic Study of ND0612H and ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson’s Disease (Tue 7:00AM EST)


Precious Metals on Watch: Gold, Silver

GDX and SLV have each been maintaining higher highs and higher lows since reaching a bottom in November. As we head into the New Year, we’re going to devote a good amount of focus to gold and silver, and tracking these indices and their options chains is going to be a good way to do that.

In particular, we’re going to be monitoring a few specific sets of contracts for each play:

  SLV – March $15-15.50 Calls

GDX – March $17.50-$18 Calls

As you can see from the side-by-side chart we drew up below, GDX and SLV are looking similarly ripe. We’ve got SLV breaking the 50-Line on the RSI, and GDX following closely behind in that regard, we’re seeing testing of the 50DMA’s on both charts, and each of the MACD’s are giving the indication of bullish crosses.


Side Note:
We’re also going to radar HMCP, a sub-penny momentum play that has had an interesting past few sessions.


Extended Watchlist:
NRX, RDHL, MIG, CYTK, NEON, BCLI, CVEO